Literature DB >> 22015491

Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection.

Keisuke Kato1, Yasuko Kojima, Chie Kobayashi, Kazumasa Mitsui, Ryoko Nakajima-Yamaguchi, Kazuko Kudo, Toshihiro Yanai, Ai Yoshimi, Tomohei Nakao, Tomohiro Morio, Mureo Kasahara, Kazutoshi Koike, Masahiro Tsuchida.   

Abstract

We report two patients with chronic granulomatous disease (CGD). The first patient presented with granulomatous colitis and pulmonary aspergillosis, and the second patient with liver abscess and restrictive pulmonary disorder. Both patients underwent allogeneic hematopoietic stem cell transplantation, the first from an HLA-matched sibling donor, and the second from an HLA-matched unrelated donor, after preconditioning with fludarabine, anti-thymocyte globulin, cyclophosphamide, and total-body irradiation of 3 Gy. The engraftment was prompt and the regimen-related toxicity was mild. The patients are able to return to their daily lives with full donor chimerism, although the second patient underwent a living-related-donor orthotopic liver transplantation from his mother for chronic liver graft-versus-host disease. The conditioning regimen we used was feasible and applicable to patients with CGD accompanied by inflammatory disease and severe infection.

Entities:  

Mesh:

Year:  2011        PMID: 22015491     DOI: 10.1007/s12185-011-0932-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

1.  Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection.

Authors:  Jairam Sastry; Alyson Kakakios; Heidi Tugwell; Peter J Shaw
Journal:  Pediatr Blood Cancer       Date:  2006-09       Impact factor: 3.167

Review 2.  Chronic granulomatous disease and other disorders of phagocyte function.

Authors:  Mary C Dinauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

3.  Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.

Authors:  O Ringdén; M Remberger; T Ruutu; J Nikoskelainen; L Volin; L Vindeløv; T Parkkali; S Lenhoff; B Sallerfors; L Mellander; P Ljungman; N Jacobsen
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

4.  Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.

Authors:  M E Horwitz; A J Barrett; M R Brown; C S Carter; R Childs; J I Gallin; S M Holland; G F Linton; J A Miller; S F Leitman; E J Read; H L Malech
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

5.  Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.

Authors:  Tayfun Güngör; Jörg Halter; Anne Klink; Sonja Junge; Katrin D M Stumpe; Reinhard Seger; Urs Schanz
Journal:  Transplantation       Date:  2005-06-15       Impact factor: 4.939

6.  Sequential reduced- and full-intensity allografting using same donor in a child with chronic granulomatous disease and coexistent, significant comorbidity.

Authors:  J A T Nicholson; R F Wynn; T F Carr; A M Will
Journal:  Bone Marrow Transplant       Date:  2004-12       Impact factor: 5.483

7.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

Review 8.  Late effects in children after bone marrow transplantation: a review.

Authors:  F Locatelli; G Giorgiani; A Pession; M Bozzola
Journal:  Haematologica       Date:  1993 Sep-Oct       Impact factor: 9.941

9.  Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.

Authors:  P Ljungman; M Hassan; A N Békássy; O Ringdén; G Oberg
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

Review 10.  Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature.

Authors:  I Del Giudice; A P Iori; A Mengarelli; A M Testi; A Romano; R Cerretti; F Macrì; M Iacobini; W Arcese
Journal:  Ann Hematol       Date:  2003-02-12       Impact factor: 3.673

View more
  9 in total

Review 1.  Newcomers in paediatric GI pathology: childhood enteropathies including very early onset monogenic IBD.

Authors:  Arzu Ensari; Judith Kelsen; Pierre Russo
Journal:  Virchows Arch       Date:  2017-07-17       Impact factor: 4.064

Review 2.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

Review 3.  The role of monogenic disease in children with very early onset inflammatory bowel disease.

Authors:  Judith R Kelsen; Robert N Baldassano
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

Review 4.  Genomic and Immunologic Drivers of Very Early-Onset Inflammatory Bowel Disease.

Authors:  Maire A Conrad; Judith R Kelsen
Journal:  Pediatr Dev Pathol       Date:  2019-03-06

5.  Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry.

Authors:  Brenna LaBere; Maria J Gutierrez; Hannah Wright; Elizabeth Garabedian; Hans D Ochs; Ramsay L Fuleihan; Elizabeth Secord; Rebecca Marsh; Kathleen E Sullivan; Charlotte Cunningham-Rundles; Luigi D Notarangelo; Karin Chen
Journal:  J Allergy Clin Immunol Pract       Date:  2022-01-14

6.  Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease.

Authors:  Judith R Kelsen; Robert N Baldassano; David Artis; Gregory F Sonnenberg
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-09-01

Review 7.  Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease.

Authors:  Jodie Deborah Ouahed
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

Review 8.  Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.

Authors:  Jodie Ouahed; Elizabeth Spencer; Daniel Kotlarz; Dror S Shouval; Matthew Kowalik; Kaiyue Peng; Michael Field; Leslie Grushkin-Lerner; Sung-Yun Pai; Athos Bousvaros; Judy Cho; Carmen Argmann; Eric Schadt; Dermot P B Mcgovern; Michal Mokry; Edward Nieuwenhuis; Hans Clevers; Fiona Powrie; Holm Uhlig; Christoph Klein; Aleixo Muise; Marla Dubinsky; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2020-05-12       Impact factor: 5.325

Review 9.  The diagnostic approach to monogenic very early onset inflammatory bowel disease.

Authors:  Holm H Uhlig; Tobias Schwerd; Sibylle Koletzko; Neil Shah; Jochen Kammermeier; Abdul Elkadri; Jodie Ouahed; David C Wilson; Simon P Travis; Dan Turner; Christoph Klein; Scott B Snapper; Aleixo M Muise
Journal:  Gastroenterology       Date:  2014-07-21       Impact factor: 33.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.